Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 601 to 625 of 2489

TitleReference numberPublishedLast updated
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295
Granulox for managing chronic non-healing woundsMIB296
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Liposuction for chronic lymphoedemaIPG723
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Diabetes in children and young peopleQS125
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Liposuction for chronic lipoedemaIPG721
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Joint replacement (primary): hip, knee and shoulderQS206
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18

Results per page

  1. 10
  2. 25
  3. 50
  4. All